Development of a rapid assay for screening point mutations associated with quinolone resistance in the Pseudomonas aeruginosa parC gene
- 1 January 2000
- journal article
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 6 (1) , 26-29
- https://doi.org/10.1007/s101560050045
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Cloning, Expression, and Enzymatic Characterization of Pseudomonas aeruginosa Topoisomerase IVAntimicrobial Agents and Chemotherapy, 1999
- Type II Topoisomerase Mutations in Ciprofloxacin-Resistant Strains of Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1999
- Mutations in the gyrA and parC genes in fluoroquinolone-resistant clinical isolates of Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1997
- Mutations in the gyrA and parC genes associated with fluoroquinolone resistance in clinical isolates of Citrobacter freundiiFEMS Microbiology Letters, 1997
- Topoisomerase IV is a target of quinolones in Escherichia coli.Proceedings of the National Academy of Sciences, 1995
- Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1995
- Outer membrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1995
- Cloning and nucleotide sequence of Pseudomonas aeruginosa DNA gyrase gyrA gene from strain PAO1 and quinolone-resistant clinical isolatesAntimicrobial Agents and Chemotherapy, 1994
- Ofloxacin-resistant Pseudomonas aeruginosa mutants with elevated drug extrusion across the inner membraneBiochemical and Biophysical Research Communications, 1991
- Modification of enzymatic-ally amplified DNA for the detection of point mutationsNucleic Acids Research, 1989